As I mentioned last week, these numbers apply to NIH issued RFAs only, not FDA or other agency-funded RFAs.
Also, I think it might help to review some terminology. “RFA” stands for a Request for Applications. This mechanism sets money aside for a specific focal area of research. ME/CFS last had an RFA in 2006.
“FOA” stands for Funding Opportunity Announcement, also known as a “PA” or Program Announcement. These announcements indicate NIH’s interest in grant applications in a specific area, but there is no set aside funding. For example, NIH is very interested in Zika virus applications right now.
The last Program Announcement for ME/CFS expired on February 25, 2015. Researchers can still submit grants, but there is no current statement of interest from any Institute at NIH that I can find. Of course, one would hope that this would be a priority for the Trans-NIH ME/CFS Working Group, but we don’t really have any insight into that process or timeline.
All in all, I think we can say that ME/CFS got a goose egg instead of an Easter egg last week.
- Total RFAs Issued by NIH: 163 (October 2015 to date)
- Total Dollars Committed to RFAs: $1,719,800,000 (October 2015 to date)
- Total RFAs for ME/CFS: ZERO (October 2015 to date)
|Week Beginning||RFAs Issued||Total Commitment||RFAs for ME/CFS|
If you want more background on the RFA Ticker, read the inaugural post.